- Home
- FCUV vs BCAB Comparison
FCUV vs BCAB Comparison
Compare FCUV & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCUV
- BCAB
- Stock Information
- Founded
- FCUV 2012
- BCAB 2007
- Country
- FCUV United States
- BCAB United States
- Employees
- FCUV N/A
- BCAB N/A
- Industry
- FCUV Industrial Machinery/Components
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- FCUV Industrials
- BCAB Health Care
- Exchange
- FCUV Nasdaq
- BCAB Nasdaq
- Market Cap
- FCUV 26.5M
- BCAB 27.0M
- IPO Year
- FCUV N/A
- BCAB 2020
- Fundamental
- Price
- FCUV $4.18
- BCAB $0.32
- Analyst Decision
- FCUV
- BCAB Buy
- Analyst Count
- FCUV 0
- BCAB 2
- Target Price
- FCUV N/A
- BCAB $1.00
- AVG Volume (30 Days)
- FCUV 25.9K
- BCAB 534.2K
- Earning Date
- FCUV 05-14-2025
- BCAB 05-13-2025
- Dividend Yield
- FCUV N/A
- BCAB N/A
- EPS Growth
- FCUV N/A
- BCAB N/A
- EPS
- FCUV N/A
- BCAB N/A
- Revenue
- FCUV $398,137.00
- BCAB $11,000,000.00
- Revenue This Year
- FCUV N/A
- BCAB N/A
- Revenue Next Year
- FCUV N/A
- BCAB N/A
- P/E Ratio
- FCUV N/A
- BCAB N/A
- Revenue Growth
- FCUV N/A
- BCAB N/A
- 52 Week Low
- FCUV $1.50
- BCAB $0.24
- 52 Week High
- FCUV $10.90
- BCAB $3.53
- Technical
- Relative Strength Index (RSI)
- FCUV 49.87
- BCAB 47.24
- Support Level
- FCUV $4.02
- BCAB $0.26
- Resistance Level
- FCUV $4.55
- BCAB $0.34
- Average True Range (ATR)
- FCUV 0.46
- BCAB 0.04
- MACD
- FCUV 0.05
- BCAB 0.00
- Stochastic Oscillator
- FCUV 55.68
- BCAB 58.18
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.